Penumbra Inc (NYSE:PEN)
$ 186.94 -13.07 (-6.53%) Market Cap: 7.26 Bil Enterprise Value: 7.66 Bil PE Ratio: 549.82 PB Ratio: 6.25 GF Score: 82/100

Penumbra Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 11, 2019 / 09:00PM GMT
Release Date Price: $165.21 (-0.22%)
Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst

Okay. Good. I think in the interest of time we'll make a start. Welcome, again, to day 1 of the Goldman Sachs Global Healthcare Conference. My name is Chris Cooper. I'm a health care analyst here at Goldman Sachs. It gives me a great pleasure to introduce Penumbra. So look, I don't know if you guys want to start with maybe just an introductory line or 2 or we can just go straight into it.

Adam Elsesser
Penumbra, Inc. - Co Founder, Chairman, CEO & President

Why don't we get straight into it?

Questions & Answers

Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst

Sure. Absolutely. So look, I mean, maybe we can just make a start on product portfolio. I know you've launched a couple of new products with JET 7 last year. Can you just give us an update on how that's going, please?

Adam Elsesser
Penumbra, Inc. - Co Founder, Chairman, CEO & President

So just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot